CV Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: April 02, 2026
Report Source: 2025 Annual Report
CapsoVision Inc. Stock Analysis CV
CapsoVision, Inc. operates as a commercial-stage medical technology company. The company is headquartered in Saratoga California, California and currently employs 28 full-time employees. The company went IPO on 2025-07-02. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
Read More CapsoVision Inc (CV) Chart
Key Statistics of CapsoVision Inc (CV)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$6.50Volume
124.37KP/E Ratio (TTM)
-52 Week Range
Market Cap
351.86MAvg. Volume
122.88KDividend Yield
-Financial Metrics & Statements of CapsoVision Inc (CV)
FAQ's for CapsoVision Inc (CV)
- According to Musaffa’s Shariah screening methodology, CapsoVision Inc (CV) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.